U.S. Allies Seek Trade Deals with China Amid Trump's Tariff Threats
Facing tariff threats from the United States, some of its long-standing allies are reportedly diversifying their trade relationships, turning to China and India for potential deals. According to NPR, President Trump's tariffs and rhetoric have spurred this shift, with allies looking to Asian superpowers to secure their economic interests.
The move comes as the U.S. imposes or threatens tariffs on goods from various countries, prompting concerns about trade stability and economic security among its allies. The specific countries seeking deals with China and India were not detailed in the reports, but the trend indicates a potential realignment of global trade dynamics.
In other news, Life Biosciences, a Boston-based startup, received FDA approval to begin the first human trial of a rejuvenation method aimed at treating eye disease. According to MIT Technology Review, the company plans to use a "reprogramming" concept to attempt age reversal in human volunteers. This approach has attracted significant investment from Silicon Valley firms.
Billionaire financier Ross Stevens is set to donate $100 million to U.S. Olympic and Paralympic athletes. Starting with the upcoming Milan Cortina Olympics, every athlete will receive $200,000, even if they do not win a medal, according to Hacker News. Half of the money will be given 20 years after their first qualifying Olympic appearance or at age 45, whichever comes later, and the other half will be a guaranteed benefit for their families.
The UK government recently launched its AI Skills Hub, aiming to provide 10 million workers with AI skills by 2030. However, the website, delivered by PwC, cost £4.1 million (approximately $5.66 million) and has been criticized for its poor user interface. According to Hacker News, the site primarily links to external resources, such as Salesforce's Trailhead learning platform, and does not contain original course content.
Discussion
Join the conversation
Be the first to comment